Rowena Green
Executive Director, Quality Assurance @ Clene Nanomedicine
p8b23p@juq37.thx
Sign up to see email
Known information
- Joined Clene Nanomedicine, Inc. in 2015
- Has over twenty-three years of GxP experience
- Spent three years as a consultant at Meridian BioGroup
- Worked with Johns Hopkins University as the Quality Manager of the Cell Processing and Gene Therapy Department
- Holds a Bachelor of Science Degree in Chemistry
- Worked as a Manufacturing Operator to produce brain cancer treatment
- Developed clinical trial projects to manufacture API as a Research Associate in Chemical Development
- Performed data review for one of the largest MRSA clinical studies ever conducted as a Sr. Quality Assurance representative
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.